Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-24 @ 4:11 PM
NCT ID:
NCT00822666
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18
* Male gender
* Included in the AFIJI registry
* No high bleeding risk profile
* No recent history of acute coronary syndrome (\< 3 months)
* Written informed consent obtained
* Genotype CYP2C19 : \*1/\*1, \*1/\*2 ou \*2/\*2
* Genotype P2Y12 : H1/H1 ou H1/H2
Exclusion Criteria:
* Female gender
* Patient with a contraindication to clopidogrel
* Patient who has received a loading dose of clopidogrel in the past 7 days
* Patient treated with ticlopidine or GP2B/3A receptor antagonist prior to loading
* Non compliance
* Génotype P2Y12 : H2/H2.
* Patient treated with drugs interacting with platelet aggregation (NSAID, persantine, serotonin inhibitors )
* Patient treated with drugs interacting 2C19
* Not affiliated to the national health insurance
* Patient participating to another randomized study
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00822666
Study Brief:
Protocol Section:
NCT00822666